Two Sigma Advisers
IMGN

Two Sigma Advisers’s Immunogen Inc IMGN Stock Holding History

Two Sigma Advisers’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-523,118
Closed -$15.5M – 2703
2023
Q4 		$15.5M Sell
523,118
-771,400
-60% -$15.4M 0.04% 394
2023
Q3 		$20.5M Buy
1,294,518
+108,400
+9% +$1.8M 0.05% 305
2023
Q2 		$22.4M Sell
1,186,118
-1,744,500
-60% -$20.6M 0.06% 285
2023
Q1 		$11.3M Sell
2,930,618
-348,500
-11% -$1.49M 0.03% 517
2022
Q4 		$16.3M Buy
3,279,118
+266,700
+9% +$1.45M 0.05% 390
2022
Q3 		$14.4M Buy
3,012,418
+185,600
+7% +$978K 0.04% 397
2022
Q2 		$12.7M Buy
2,826,818
+364,900
+15% +$1.59M 0.04% 446
2022
Q1 		$11.7M Buy
2,461,918
+301,600
+14% +$1.67M 0.03% 457
2021
Q4 		$16M Buy
2,160,318
+12,596
+0.6% +$78.3K 0.04% 363
2021
Q3 		$12.2M Sell
2,147,722
-826,596
-28% -$4.78M 0.03% 454
2021
Q2 		$19.6M Buy
2,974,318
+26,400
+0.9% +$184K 0.05% 339
2021
Q1 		$23.9M Buy
2,947,918
+310,000
+12% +$2.53M 0.07% 322
2020
Q4 		$17M Buy
2,637,918
+649,100
+33% +$3.79M 0.05% 391
2020
Q3 		$7.16M Buy
1,988,818
+885,200
+80% +$3.57M 0.02% 632
2020
Q2 		$5.08M Buy
1,103,618
+99,600
+10% +$424K 0.01% 787
2020
Q1 		$3.42M Buy
1,004,018
+351,700
+54% +$1.54M 0.01% 863
2019
Q4 		$3.33M Buy
652,318
+133,500
+26% +$453K 0.01% 1001
2019
Q3 		$1.26M Buy
518,818
+29,100
+6% +$77.3K ﹤0.01% 1335
2019
Q2 		$1.06M Buy
489,718
+103,500
+27% +$245K ﹤0.01% 1488
2019
Q1 		$1.05M Buy
386,218
+179,700
+87% +$778K ﹤0.01% 1509
2018
Q4 		$991K Buy
206,518
+113,384
+122% +$688K ﹤0.01% 1482
2018
Q3 		$882K Sell
93,134
-224,500
-71% -$2.16M ﹤0.01% 1553
2018
Q2 		$3.09M Sell
317,634
-366,818
-54% -$3.87M 0.01% 1084
2018
Q1 		$7.2M Buy
684,452
+90,900
+15% +$898K 0.02% 709
2017
Q4 		$3.81M Buy
+593,552
New +$3.66M 0.01% 955
2017
Q1 		– Sell
-32,052
Closed -$65K – 2500
2016
Q4 		$65K Sell
32,052
-7,000
-18% -$14.1K ﹤0.01% 2292
2016
Q3 		$105K Sell
39,052
-113,966
-74% -$331K ﹤0.01% 2132
2016
Q2 		$471K Buy
+153,018
New +$959K ﹤0.01% 1546
2015
Q4 		– Sell
-18,618
Closed -$179K – 2058
2015
Q3 		$179K Buy
18,618
+2,900
+18% +$42.4K ﹤0.01% 1661
2015
Q2 		$226K Buy
+15,718
New +$173K ﹤0.01% 1711

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Advisers's IMGN Position: Q1 2024 in Review

Two Sigma Advisers sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 523,118 shares — an estimated $15.5M sold.

Two Sigma Advisers first reported a position in IMGN in Q2 2015 and held it in 30 quarters. The position peaked at $23.9M in Q1 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Two Sigma Advisers reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 523,118 Immunogen Inc shares in Q1 2024, an estimated $15.5M.
  • Two Sigma Advisers first reported a position in Immunogen Inc in Q2 2015 and held it in 30 quarters.
  • Two Sigma Advisers's Immunogen Inc position peaked at $23.9M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.